Loading: 100%
OMNICELL, Inc logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 2,345 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker OMCLno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 173036424854
datesClosing price (adj.)
13.10.201750.85
11.10.201751.55
04.10.201752.35
27.09.201749.75
20.09.201748.20
13.09.201750.10
06.09.201750.15
30.08.201750.25
23.08.201749.20
16.08.201750.60
09.08.201750.15
02.08.201750.40
26.07.201743.15
19.07.201743.05
12.07.201743.50
05.07.201743.10
27.06.201743.80
20.06.201742.65
13.06.201743.05
06.06.201742.25
30.05.201740.55
23.05.201741.10
16.05.201740.80
09.05.201741.35
02.05.201741.50
25.04.201740.85
18.04.201740.25
11.04.201740.75
04.04.201740.10
28.03.201740.05
21.03.201739.60
14.03.201738.50
07.03.201737.50
28.02.201738.03
21.02.201738.05
14.02.201738.20
07.02.201736.60
31.01.201735.90
24.01.201734.35
17.01.201732.55
10.01.201732.55
03.01.201734.40
27.12.201634.25
19.12.201634.15
12.12.201634.65
05.12.201634.35
28.11.201634.95
21.11.201634.90
14.11.201631.85
07.11.201632.15
31.10.201632.63
24.10.201635.90
17.10.201635.75
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
50.85n/a
Market Capitalisation
in million USD
1,905n/a
Enterprise Value
in million USD
2,072n/a
Common Shares Outstanding
as per Jul 27, 2017
37,453,725n/a
Preferred Shares Outstanding
as per Jul 27, 2017
n/a
Average Basic Shares Outstanding
TTM
36,747,250n/a
Average Diluted Shares Outstanding
TTM
37,455,250n/a
Index Membership
n/a
Business Summary
Omnicell Inc provides automation and business analytics software solutions for patient-centric medication and supplies management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 680n/a
Gross Profit 298n/a
Operating Income -15n/a
EBITDA 0n/a
Net Profit -8n/a
Balance Sheet
Cash and Cash Equivalents 27n/a
Receivables 151n/a
Total Current Assets 296n/a
PP&E 41n/a
Total Assets 910n/a
Accounts Payable 53n/a
Current Debt 11n/a
Total Current Liabilities 212n/a
Long-Term Debt 184n/a
Total Liabilities 460n/a
Total Equity 450n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 43.8%n/a
Operating Margin -2.2%n/a
Net Profit Margin -1.1%n/a
Return on Equity -1.7%n/a
Return on Assets -0.9%n/a
Per Share Figures
Basic EPS -0.21n/a
Diluted EPS -0.21n/a
Sales per Share 18.51n/a
Book Value per Share 12.23n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio -240.27n/a
Price to Sales Ratio 2.75n/a
Price to Book Value 4.16n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 3.05n/a
Book to Market Value 0.24n/a
Other Ratios
Current Ratio 139.8%n/a
Liabilities to Equity Ratio 102.4%n/a
Debt to Assets Ratio 21.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
213
222
246
314
381
441
485
693
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-108
-104
-110
-143
-177
-207
-237
-379
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
105
118
136
171
203
234
248
314
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-103
-107
-120
-143
-168
-184
-203
-307
Selling, General & Administrative
-86
-86
-98
-120
-139
-156
-168
-250
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-18
-21
-22
-24
-29
-28
-35
-58
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
2
11
16
27
35
50
45
6
Non-Operating Income (Loss)
0
0
0
0
0
-1
-2
-8
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
-1
-2
-8
Pretax Income (Loss), Adjusted
2
11
16
27
35
49
43
-2
Abnormal Gains (Losses)
-1
-1
0
0
0
0
3
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
1
10
16
27
35
49
46
-2
Income Tax (Expense) Benefit, net
-1
-5
-6
-11
-11
-18
-15
3
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
0
5
10
16
24
31
31
1
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
0
5
10
16
24
31
31
1
Minority Interest
0
0
0
0
0
0
0
0
Net Income
0
5
10
16
24
31
31
1
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
0
5
10
16
24
31
31
1
Remarks
restated on Mar 8, 2012 n/a
calculated values,
restated on Mar 11, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 30, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
184
200
62
105
126
82
54
Cash & Cash Equivalents
n/a
176
192
62
105
126
82
54
Short Term Investments
n/a
8
8
0
0
0
0
0
Accounts & Notes Receivable
n/a
43
39
55
59
83
108
150
Accounts Receivable, Net
n/a
43
39
55
59
83
108
150
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
10
18
27
31
32
47
69
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
28
27
36
39
43
27
41
Prepaid Expenses
n/a
12
10
15
19
24
20
29
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
9
10
12
13
12
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
7
6
9
8
7
8
13
Total Current Assets
n/a
265
284
181
234
283
264
315
Property, Plant & Equipment, Net
n/a
14
17
34
35
36
32
42
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
9
9
13
11
11
14
21
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
55
54
214
212
230
268
557
Intangible Assets
n/a
5
4
86
82
83
90
190
Goodwill
n/a
29
29
111
111
123
148
328
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
13
12
1
1
1
2
4
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
8
10
16
18
23
28
35
Total Noncurrent Assets
n/a
79
80
261
259
277
315
620
Total Assets
n/a
343
364
442
493
560
579
935
Liabilities and owners' equity
Payables & Accruals
n/a
30 29657000
27 27229000
42 41856000
50 49821000
59 58605000
71 70974000
85 84986000
Accounts Payable
n/a
13 13242000
11 11000000
18 18255000
16 16471000
19 19432000
23 22646000
27 27069000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
16 16415000
16 16229000
24 23601000
33 33350000
39 39173000
48 48328000
58 57917000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
8 8410000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
29 28507000
33 33401000
41 41221000
43 42583000
54 53725000
54 53656000
88 87516000
Deferred Revenue
n/a
29 28507000
33 33401000
41 41221000
43 42583000
54 53725000
54 53656000
88 87516000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
58 58164000
61 60630000
83 83077000
92 92404000
112 112330000
125 124630000
181 180912000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
246 245731000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
20 19846000
20 20305000
51 51192000
51 51100000
58 57786000
52 51729000
77 76853000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
26 26491000
28 28162000
30 30454000
22 21822000
52 51592000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
20 19846000
20 20305000
25 24701000
23 22938000
27 27332000
30 29907000
25 25261000
Total Noncurrent Liabilities
n/a
20 19846000
20 20305000
51 51192000
51 51100000
58 57786000
52 51729000
323 322584000
Total Liabilities
n/a
78 78010000
81 80935000
134 134269000
144 143504000
170 170116000
176 176359000
503 503496000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
342 342309000
362 362192000
383 382883000
421 421273000
457 457479000
490 490399000
526 525804000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-65 -65064000
-78 -77637000
-90 -90000000
-111 -110962000
-135 -135053000
-185 -185074000
-185 -185074000
Retained Earnings
n/a
-12 -12031000
-2 -1642000
15 14536000
39 38515000
69 69033000
100 99793000
100 100396000
Other Equity
n/a
0 0
0 1000
0 131000
0 171000
-1 -1361000
-3 -2730000
-10 -9519000
Equity Before Minority Interest
n/a
265 265214000
283 282914000
308 307550000
349 348997000
390 390098000
402 402388000
432 431607000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
265 265214000
283 282914000
308 307550000
349 348997000
390 390098000
402 402388000
432 431607000
Total Liabilities & Equity
n/a
343 343224000
364 363849000
442 441819000
493 492501000
560 560214000
579 578747000
935 935103000
Remarks restated on n/a restated on Mar 8, 2012 n/a restated on Mar 11, 2013 n/a restated on Mar 17, 2014 n/a restated on Mar 30, 2015 n/a restated on Feb 26, 2016 n/a restated on Feb 28, 2017 n/a restated on Aug 4, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
0
5
10
16
24
31
31
1
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
9
9
8
13
18
20
26
58
Non-Cash Items
0
6
9
9
12
13
12
19
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
31
4
-2
-16
-9
-20
-31
-23
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
40
23
25
23
46
44
37
55
Change in Fixed Assets & Intangibles
-4
-7
-9
-15
-13
-12
-8
-15
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
-6
0
-156
0
-21
-26
-312
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
-3
-10
-4
3
-8
-10
-12
-14
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-7
-23
-13
-169
-20
-43
-46
-341
Dividends Paid
0
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
0
253
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
4
7
-6
-2
6
-2
-33
18
Increase in Capital Stock
4
7
7
10
27
22
17
18
Decrease in Capital Stock
0
0
-13
-12
-21
-24
-50
0
Other Financing Activities
5
2
4
2
1
2
1
-5
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
9
9
-2
0
7
0
-32
266
Net Cash Before Disc. Operations and FX
43
9
10
-146
33
0
-41
-21
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
43
9
10
-146
33
0
-41
-21
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
Net Changes in Cash
43
9
10
-146
33
0
-41
-21
Remarks
restated on Mar 8, 2012 n/a
calculated values,
restated on Mar 11, 2013 n/a
calculated values,
restated on Mar 17, 2014 n/a
calculated values,
restated on Mar 30, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo